• Western blot analysis of lysates from Jurkat cells, using MBD3 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using MBD3 Polyclonal Antibody

Anti-MBD3 antibody (221-270 aa) (STJ94036)

SKU:
STJ94036

Current Stock:
Host: Rabbit
Applications: WB/ELISA/IHC
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Methyl-CpG-binding domain protein 3 (221-270 aa) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
ELISA 2000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MBD3
Gene ID: 53615
Uniprot ID: MBD3_HUMAN
Immunogen Region: 221-270 aa
Specificity: MBD3 Polyclonal Antibody detects endogenous levels of MBD3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human MBD3 at the amino acid range 221-270
Protein Name Methyl-Cpg-Binding Domain Protein 3
Methyl-Cpg-Binding Protein Mbd3
Database Links Reactome: R-HSA-3214815
Reactome: R-HSA-427389
Reactome: R-HSA-6804758
Reactome: R-HSA-73762
Reactome: R-HSA-8943724
Reactome: R-HSA-9679191
Cellular Localisation Nucleus
Chromosome
Nuclear
In Discrete Foci
Detected On Chromatin
At Promoter Regions Of Active Genes
Alternative Antibody Names Anti-Methyl-Cpg-Binding Domain Protein 3 antibody
Anti-Methyl-Cpg-Binding Protein Mbd3 antibody
Anti-MBD3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance